Trials / Completed
CompletedNCT03658876
Predictors of Response to Iron and Erythropoietin Stimulating Agents
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 197 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to identify predictors of treatment response. This involves collected baseline clinical parameters and bloods for biochemical parameters prior to administering the study treatment. A positive outcome following treatment was defined as an uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the participants response to treatment against the clinical and biochemical information collected prior to treatment being received.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iron Sucrose Solution for Injection | 200mg iron sucrose given on 5 successive haemodialysis sessions |
| DRUG | Epoetin Beta | Uptitration of epoetin beta dose. Scale as follows (in units /session): 0-1000-2000-3000-4000-6000-8000-12000 |
Timeline
- Start date
- 2015-06-03
- Primary completion
- 2016-12-31
- Completion
- 2017-12-31
- First posted
- 2018-09-05
- Last updated
- 2019-07-05
- Results posted
- 2019-07-05
Source: ClinicalTrials.gov record NCT03658876. Inclusion in this directory is not an endorsement.